A Long Term Study of YM060 in Female Patients With Diarrhea-predominant Irritable Bowel Syndrome
Status:
Completed
Trial end date:
2014-05-01
Target enrollment:
Participant gender:
Summary
To evaluate the efficacy and safety of YM060 once daily for female patients with
diarrhea-predominant irritable bowel syndrome (D-IBS) for a long-term period (up to 52
weeks).